Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatoma-derived growth factor, related protein 3 (HDGFRP3), also known as HDGFL3 or HRP-3, is a member of the HDGF protein family and functions primarily as a growth factor with structural similarity to HDGF but distinct expression, being mainly found in nervous tissues[2][3][6][7]. This protein contains a conserved PWWP domain implicated in chromatin association, DNA binding (mainly nonspecific), and possible regulation of gene expression[1][2]. HDGFRP3 enhances DNA synthesis and cell proliferation, and is involved in mitogenic, angiogenic, and anti-apoptotic processes; it has also been shown to play roles in neural development, neuroprotection, and maintenance of neurons, as well as tumorigenesis[2][3][6][7]. It is considered a potential target for therapeutic intervention in cancer and neurodegenerative diseases, but no clinically approved drugs currently target this protein directly[2][3].
Targeting proliferation (as a mitogen); Targeting angiogenesis; Anti-apoptotic signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatoma-derived growth factor, related protein 3 (HDGFRP3).